San Diego, CA, United States of America

Masanao Tsuda

This inventor holds 1 USPTO granted patent. Top assignee: Chemregen, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masanao Tsuda. Retrieved from https://idiyas.com/inventor/masanao-tsuda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Masanao Tsuda

Introduction

Masanao Tsuda is a prominent inventor based in San Diego, California. He has made significant contributions to the field of cancer research through his innovative work. His dedication to developing new methods for cancer treatment has led to the creation of a noteworthy patent.

Latest Patents

Masanao Tsuda holds a patent for "Compounds for inhibition of cancer cell proliferation." This patent includes methods and small molecule compounds designed to inhibit the proliferation of cancer cells. One example of the compounds covered by this patent is represented by a specific formula, which includes various components as described in the patent documentation.

Career Highlights

Tsuda's career is marked by his commitment to advancing medical science, particularly in oncology. His work at Chemregen, Inc. has positioned him as a key player in the development of therapeutic solutions aimed at combating cancer. His innovative approach and research have garnered attention in the scientific community.

Collaborations

Masanao Tsuda collaborates with notable colleagues, including John R. Cashman and Mark Mercola. These partnerships enhance the research efforts at Chemregen, Inc. and contribute to the advancement of cancer treatment methodologies.

Conclusion

Masanao Tsuda's contributions to cancer research through his patent and collaborative efforts highlight his role as an influential inventor in the field. His work continues to inspire advancements in medical science and offers hope for improved cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…